(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of 8.3% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 2.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Petmed Express's revenue in 2024 is $276,967,000.On average, 1 Wall Street analysts forecast PETS's revenue for 2025 to be $6,677,255,376, with the lowest PETS revenue forecast at $6,677,255,376, and the highest PETS revenue forecast at $6,677,255,376.
In 2026, PETS is forecast to generate $6,870,765,908 in revenue, with the lowest revenue forecast at $6,870,765,908 and the highest revenue forecast at $6,870,765,908.